News

Montana Bioscience Alliance Fall 2023 Newsletter

October 17, 2023/

New Diagnostic Tests Could Change The Landscape For Leukemia Prevention And Treatment

 

Inimmune Corporation announces First Subject Dosed in First-in-Human Phase 1 Clinical Trial of its novel intranasal TLR4 agonist, INI-2004, for the Treatment of Allergic Rhinitis and FDA Clearance of IND application for INI-2004

 

Solo-Dex Nominated for Prestigious 2023 Prix Galien USA Awards

and  much more….


Click here to read the story.

Related Stories

  1. Montana Bioscience Cluster Initiative October 2023 Newsletter
  2. Upcoming Webinar on Bioscience Workforce Trends in Montana
  3. Montana Department of Labor forecasts steady job growth over the next decade

Leave a Comment

You must be logged in to post a comment.

News Catrgory Sponspor:


Montana Bioscience Cluster Initiative - Collaborative program design and execution and integrated programs fostering innovation, technology commercialization, entrepreneurship and sustainable small businesses

News Catrgory Sponspor:


Dorsey & Whitney - An International business law firm, applying a business perspective to clients' needs in Missoula, Montana and beyond.

MATR Supporters (view all)


Montana Bioscience Cluster Initiative - Collaborative program design and execution and integrated programs fostering innovation, technology commercialization, entrepreneurship and sustainable small businesses

For over 25 years, Zoot Enterprises has been a global provider of advanced origination, acquisition, and decision management solutions.

Prospera helps businesses and communities find their pathway to success, acting as the navigator, problem solver and catalyst for a strong Montana economy.